Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners

V Barrios1, C Escobar, A Calderón

  • 1Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain. vbarriosa@meditex.es

Insights

Spanish hypertensive patients often have multiple cardiovascular risk factors. Physicians, including general practitioners and specialists, frequently underestimate patient risk, especially in high-risk individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Practice

Background:

  • Hypertension management requires accurate cardiovascular risk assessment.
  • European guidelines provide a framework for risk stratification.
  • Understanding physician adherence to guidelines is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the cardiovascular risk profile of hypertensive patients in Spain.
  • To assess the accuracy of cardiovascular risk stratification by primary care physicians and specialists.
  • To compare risk assessment between primary care and specialist settings.

Main Methods:

  • The CONTROLRISK study enrolled 8920 hypertensive patients from primary care and specialist clinics.
  • Data collected included patient demographics, cardiovascular risk factors, target organ damage (TOD), and associated clinical conditions (ACC).
  • Physician risk stratification was compared against 2003 European guidelines.

Main Results:

  • Over 85% of patients presented with additional cardiovascular risk factors.
  • Target organ damage and associated clinical conditions were more prevalent in the specialist setting.
  • Physicians underestimated cardiovascular risk, with correct stratification rates of 54.6% for specialists and 48% for general practitioners (GPs).
  • Underestimation was particularly significant for very high-risk patients.

Conclusions:

  • A substantial proportion of hypertensive patients in Spain, particularly those seen by GPs, are at high or very high cardiovascular risk.
  • Both GPs and specialists tend to underestimate cardiovascular risk in clinical practice.
  • Improved risk assessment and stratification are needed, especially for high-risk hypertensive patients.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...